Lorenza Rimassa
Lorenza Rimassa publishes mostly in Oncology, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Colorectal Cancer Treatments and Studies.
- World rank
- #83,404 of 7,710,434 ranked researchers
- Rank in Italy
- #1,557 of 242,206
- Works
- 766
- Citations
- 24k
- Citations per work
- 31.7
What does Lorenza Rimassa research?
Lorenza Rimassa's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences58876.7%
- Medicine58876.7%
- Everything else14518.9%
- Life Sciences344.4%
- 1Oncology27% of their works
- 2Hepatology21% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Surgery11% of their works
- 5Epidemiology7% of their works
- 6Cancer Research4% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Liver Disease Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Liver physiology and pathology
Which keywords describe Lorenza Rimassa's research?
The keywords of their largest research topics: Hepatocellular Carcinoma, Clinical Practice Guidelines, Chemotherapy, Liver Cancer, Management, Tumor Microenvironment, Biliary Tract Cancer and Cholangiocarcinoma.
- Liver Regeneration
- Gastric Cancer
- NASH
- Surgical Complications
- PD-1 and PD-L1
- KRAS Mutations
- Cholangiocarcinoma
- Tumor Microenvironment
- Liver Cancer
- Clinical Practice Guidelines
- Hepatocellular Carcinoma
- Chemotherapy
- Management
- Biliary Tract Cancer
- Cetuximab
- Immune Checkpoint Blockade
- Pancreatic Cancer
- NAFLD
- Endoscopic Resection
- Hepatic Stellate Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Hepatocellular Carcinoma3412 topics
- Clinical Practice Guidelines3262 topics
- Chemotherapy2763 topics
- Liver Cancer2761 topic
- Management2761 topic
- Tumor Microenvironment1922 topics
- Biliary Tract Cancer1411 topic
- Cholangiocarcinoma1411 topic
- Cetuximab1371 topic
- KRAS Mutations1371 topic
- Immune Checkpoint Blockade1031 topic
- PD-1 and PD-L11031 topic
- Pancreatic Cancer891 topic
- Surgical Complications891 topic
- NAFLD651 topic
- NASH651 topic
- Endoscopic Resection501 topic
- Gastric Cancer501 topic
- Hepatic Stellate Cells481 topic
- Liver Regeneration481 topic
Where does Lorenza Rimassa work?
Lorenza Rimassa's main affiliation in the publication record is Humanitas University, Italy.
How many publications and citations does Lorenza Rimassa have?
OpenAlex counts 766 works and 24,270 citations for Lorenza Rimassa, an h-index of 71, ranking #83,404 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lorenza Rimassa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.